A significant difference was observed in the levels of IL-6 and IL-7 between severe and mild patients at 1–3 days and 4–6 days since onset (Supplementary Figure 6B, p < 0.05 or p < 0.01), which is in accordance with the published literature about IL-6 as a severity predictor of COVID-19. Here, IL7 is linked to COVID-19.